<DOC>
	<DOCNO>NCT02567578</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , placebo-controlled dose-finding phase 2 trial evaluate efficacy safety YH12852 patient functional dyspepsia .</brief_summary>
	<brief_title>A Trial Evaluate Efficacy Safety YH12852 Patients With Functional Dyspepsia</brief_title>
	<detailed_description>Eligible subject randomize one 4 group ; YH12852 0.1 mg , 0.25 mg , 0.5 mg , placebo ratio administer investigational product orally , twice daily 4 week follow 2 week .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>1 . Subjects must willing able provide write informed consent . 2 . BMI &lt; 35 kg/m2 3 . Patients experience one functional dyspepsia symptom begin least 6 month prior accord Rome III criterion , symptom ( ) evident last 3 month time screen 4 . Patients evidence organic lesion base upper GI endoscopy , could cause dyspeptic symptom 5 . Women childbearing potential ( WOCBP ) must negative pregnancy test result screen visit use adequate method contraception avoid pregnancy throughout study 1 . Women pregnant breastfeeding . 2 . Women positive pregnancy test result enrollment prior investigational product administration . 3 . Subjects history surgery could affect gastrointestinal motility 4 . Subjects inflammatory bowel disease 5 . Clinically significant chronic infection ( eg . AIDS , etc ) , significant medical psychiatric illness . 6 . Serious cardiovascular disease ( include QT prolongation define QTc interval â‰¥ 450msec ) respiratory disease 7 . History alcohol drug abuse within previous one year . 8 . Subjects mental illness ( e.g . schizophrenia , dementia etc ) may render inability complete study 9 . Physical Laboratory Test Findings 10 . Administration investigational product participation clinical trial within 3 month prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>